Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 161 - 170 of 317

Selected Filters:
10 November 2022

Relative Cost-effectiveness of Long-acting Injectable Cabotegravir versus Oral Pre-exposure Prophylaxis in South Africa based on the HPTN 083 and HPTN 084 Trials: A modelled economic evaluation and threshold analysis

This article from The Lancet HIV estimates the incremental cost-effectiveness of long-acting injectable cabotegravir (CAB for PrEP) compared with tenofovir disoproxil fumarate and emtricitabine (TDF/FTC oral PrEP) in South Africa, using methods standard to government planning, and determines the threshold price at which CAB for PrEP is as cost-effective as TDF/FTC oral PrEP.

Financing & Costing, Research

External Link
10 November 2022

Examining Provincial PrEP Coverage and Characterizing PrEP Awareness and Use among Gay, Bisexual and Other Men who Have Sex with Men in Vancouver, Toronto and Montreal, 2017–2020

This article from Journal of the International AIDS Society examines differences over time in PrEP uptake and assessed factors associated with PrEP awareness and use in gay and bisexual men who have sex with men in Montreal, Toronto, and Vancouver, Canada.

Research

External Link
10 November 2022

Using Nominal Group Technique to Identify Barriers and Facilitators to Preventing HIV Using Combination Same-day Pre-exposure Prophylaxis and Medications for Opioid Use Disorder

This article from Harm Reduction Journal identifies barriers and facilitators to integrating PrEP services with provision of medications for opioid use disorder for people who use drugs in New Haven, Connecticut, USA.

Research

External Link
10 November 2022

Willingness to Pay for HIV Prevention Commodities Among Key Population Groups in Nigeria

This article from Global Health: Science and Practice investigates the willingness of gay and bisexual men who have sex with men, female sex workers, and people who use drugs to use and pay for HIV prevention commodities to support improved sustainable HIV prevention programming.

Financing & Costing, Research

External Link
10 November 2022

Bottlenecks and Solutions During Implementation of the DREAMS Program for Adolescent Girls and Young Women in Namibia

This article from Global Health: Science and Practice synthesizes implementation bottlenecks experienced while implementing the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe) program, an HIV prevention intervention for adolescent girls and young women (AGYW) in Namibia from 2017 to 2019, highlighting practical implementation issues and higher-level considerations for AGYW-centered HIV prevention programs.

Research

External Link
10 November 2022

Qualitative Inquiry into Perceptions of HIV Pre-exposure Prophylaxis among People who Inject Drugs Living with Hepatitis C in Seattle, WA, USA

This article from Harm Reduction Journal explores knowledge, attitudes, and perspectives of PrEP acceptability among people who use drugs in Seattle, Washington, USA.

Research

External Link
9 November 2022

Not PrEPared: Barriers to accessing HIV prevention drugs in England

In order to get a more comprehensive picture on what is happening with PrEP services across the UK, Terrence Higgins Trust, National AIDS Trust, PrEPster, Sophia Forum, and One Voice Network collected data from local authority sexual health commissioners, clinical staff, PrEP users, and those who sought to access PrEP. This report summarizes the findings,…

Research

Document
7 November 2022

More than Vessels: Pregnant People Deserve Inclusion in HIV Prevention Clinical and Implementation Research

Recording / Slides / Resources Pregnancy and the post-partum period after giving birth are times of heightened HIV risk. Cisgender women are two to three times more likely to acquire HIV during pregnancy and four times more likely post-partum than otherwise. Women who acquire HIV during pregnancy have an 18 percent chance of transmitting HIV…

Research

Event
3 November 2022

ICAP Grand Rounds Webinar- Long-Acting Injectable Cabotegravir for HIV Prevention: Promises and Pitfalls

Recording / Slides Two recent landmark HIV Prevention Trials Network (HPTN) studies demonstrated the efficacy of long-acting, injectable cabotegravir (CAB) as PrEP against HIV. These studies showed that CAB for PrEP injected once every eight weeks was superior to daily oral tenofovir/emtricitabine (TDF/FTC) for PrEP among cisgender men and transgender women who have sex with…

Research

Event
3 November 2022

MATRIX Project Overview

This factsheet provides an overview of USAID’s Microbicide Research and Development to Advance HIV Prevention Technologies through Responsive Innovations and Excellence (MATRIX) project.

Community/Advocacy, Research

Document